Otorrhagia
Methodology & AI Transparency ⓘ
Otorrhagia Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as H92.20, Otorrhagia falls under Eyes & Vision management, where slit-lamp biomicroscopy [Otorrhagia H92.20] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Clinical coding for Otorrhagia uses ICD-10 H92.20 across Eyes & Vision specialty care.
- 3 Typical cash cost range: Primary evaluation for Otorrhagia incorporates slit-lamp biomicroscopy [Otorrhagia H92.20] and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Otorrhagia: maintaining Intraocular Pressure (IOP) [Otorrhagia H92.20] within 10 – 21 mmHg (individualized optic target) (H92.20).
Ask our AI Specialists anything about Otorrhagia
What Is Otorrhagia?
Designated in federal medical registries as H92.20, Otorrhagia falls under Eyes & Vision management, where slit-lamp biomicroscopy [Otorrhagia H92.20] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Otorrhagia (code H92.20) is microvascular diabetic/hypertensive retinopathy [Otorrhagia H92.20], which Eye Health, Glaucoma & Vision Disorders clinicians address while surveilling Intraocular Pressure (IOP) [Otorrhagia H92.20] (10 – 21 mmHg (individualized optic target) (H92.20)).
Common Symptoms & Clinical Signs
- • Presentation of Otorrhagia (H92.20): acute eye redness, in Otorrhagia (H92.20: discharge, photophobia, or)
- • Secondary Otorrhagia clinical sign: gradual blurring, glare/halos in Otorrhagia (H92.20: around nighttime headlights,)
- • Symptom flares in Otorrhagia correlating with Intraocular Pressure (IOP) [Otorrhagia H92.20] deviation outside 10 – 21 mmHg (individualized optic target) (H92.20)
- • Functional eyes & vision impact requiring slit-lamp biomicroscopy [Otorrhagia H92.20] evaluation (H92.20)
Otorrhagia Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H92.20 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Eye Health, Glaucoma & Vision Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Otorrhagia H92.20] | 10 – 21 mmHg (individualized optic target) (H92.20) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Otorrhagia (H92.20: & OCT) | Intact retinal nerve fiber & macula (H92.20) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Systemic in Otorrhagia (H92.20: Blood Pressure) | Microvascular retinal protection (H92.20) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Otorrhagia
Treatment selection for Otorrhagia depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Otorrhagia)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on RELATIONSHIP BETWEEN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS AND NUMBER OF: What a 236-Participant Study Found A greater subretinal fluid thickness at baseline was associated with a higher frequency of pro re nata injections over 12 and 24 months in eyes treated with ranibizumab for neovascular age-related macular degeneration. Retina (Philadelphia, Pa.) • 2024-10-01 • Phase III Randomized Trial | N = 236 | 82/100 | PMID 39287532 ↗ |
| Can This Approach Help? Inside the Latest Research on Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into LHON progresses rapidly in the first months following onset during the subacute phase, followed by relative stabilization during the dynamic phase. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society • 2021-09-01 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 34310464 ↗ |
Otorrhagia Patient Community & “People Like Me” Threads
Filter Otorrhagia community threads and patient logs by age, biological sex, dosage, and treatment duration.